HALO Halozyme Therapeutics
- 39.120
- +0.150+0.38%
- 39.120
- 0.0000.00%
Halozyme Therapeutics News
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | ARS: Annual Report to Security Holders
Halozyme Therapeutics | DEFA14A: Others
Halozyme Therapeutics | DEF 14A: Definitive information statements
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Snyder Mark Howard
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBrosse Nicole
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Torley Helen
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Snyder Mark Howard
Analysis
Price Target
No Data
